TYF-ADA gene-modified autologous stem cells ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
65原発性免疫不全症候群1

65. 原発性免疫不全症候群


臨床試験数 : 500 薬物数 : 614 - (DrugBank : 119) / 標的遺伝子数 : 92 - 標的パスウェイ数 : 217
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03645460
(ClinicalTrials.gov)
October 30, 201817/7/2018Gene Transfer for ADA-SCID Using an Improved Lentiviral Vector (TYF-ADA)Gene Transfer for Adenosine Deaminase-severe Combined Immunodeficiency (ADA-SCID) Using an Improved Self-inactivating Lentiviral Vector (TYF-ADA)Adenosine DeAminase Severe Combined ImmunoDeficiency (ADA-SCID)Genetic: TYF-ADA gene-modified autologous stem cellsShenzhen Geno-Immune Medical InstituteNULLRecruiting1 MonthN/AAll10N/AChina